Retained Earnings (Accumulated Deficit) in GBP of TC BioPharm (Holdings) plc from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: GBP
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
TC BioPharm (Holdings) plc quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2022 to Q4 2024.
  • TC BioPharm (Holdings) plc Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2024 was -£52.6M, a 30.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (GBP)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Retained Earnings (Accumulated Deficit) (GBP)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 -52.6M -12.2M -30.1% Dec 31, 2024 20-F 2025-05-09
Q2 2024 -44.1M Jun 30, 2024 6-K 2024-11-25
Q1 2024 -42.2M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -40.4M -7.03M -21.1% Dec 31, 2023 20-F 2025-05-09
Q4 2022 -33.4M Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.